Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1996;28:754-757

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Erlich, Y.
Right arrow Articles by Rosenthal, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Erlich, Y.
Right arrow Articles by Rosenthal, T.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ENALAPRIL MALEATE
*FRUCTOSE
*NITRIC OXIDE

(Hypertension. 1996;28:754-757.)
© 1996 American Heart Association, Inc.


Articles

Contribution of Nitric Oxide to the Beneficial Effects of Enalapril in the Fructose-Induced Hyperinsulinemic Rat

Yael Erlich; Talma Rosenthal

the Chorley Hypertension Institute, Chaim Sheba Medical Center, Tel Hashomer and Tel Aviv (Israel) University Sackler Faculty of Medicine.

We examined accumulating evidence of the positive contribution of nitric oxide to the pharmacological effects of converting enzyme inhibitors in 36 rats rendered hypertensive, hyperinsulinemic, and hypertriglyceridemic by a fructose-enriched diet. We studied the response of blood pressure, insulin, and triglyceride levels to inhibition of either converting enzyme–kininase II, nitric oxide synthase, or both. Two weeks of the converting enzyme inhibitor enalapril (20 mg/kg) reduced blood pressure from 137±2 to 105±7 mm Hg, insulin from 7.6±2.0 to 2.2±1.1 pg/mL, and triglycerides from 292±37 to 163±37 mg/dL. Treatment with NG-nitro-L-arginine methyl ester (100 mg/kg) raised blood pressure from 144±7 to 170±8 mm Hg without affecting the other parameters. Two weeks of concomitant treatment with both agents blunted the hypotensive and beneficial metabolic effects of enalapril; thus, final blood pressure (141±7 mm Hg), insulin (6.4±2.4 pg/mL), and triglyceride (231±51 mg/dL) values were no different from those of untreated fructose-fed rats. These data suggest that persistent synthesis of nitric oxide contributes to the vasodilator and metabolic effects of enalapril in the fructose-fed rat model.


Key Words: rats • enalapril • L-NAME • fructose • hyperinsulinism




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
C. X. Zhao, X. Xu, Y. Cui, P. Wang, X. Wei, S. Yang, M. L. Edin, D. C. Zeldin, and D. W. Wang
Increased Endothelial Nitric-Oxide Synthase Expression Reduces Hypertension and Hyperinsulinemia in Fructose-Treated Rats
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 610 - 620.
[Abstract] [Full Text] [PDF]